These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
118 related items for PubMed ID: 6751178
1. The efficacy of isoproterenol inhalation for predicting the response to orally administered theophylline in chronic obstructive pulmonary disease. Dull WL, Alexander MR, Sadoul P, Woolson RF. Am Rev Respir Dis; 1982 Oct; 126(4):656-9. PubMed ID: 6751178 [Abstract] [Full Text] [Related]
3. Theophylline in stable chronic airflow obstruction. A reappraisal. Dull WL, Alexander MR. Arch Intern Med; 1984 Dec; 144(12):2399-401. PubMed ID: 6391407 [Abstract] [Full Text] [Related]
4. Isoproterenol challenge during placebo and oral theophylline therapy in chronic obstructive pulmonary disease. Dull WL, Alexander MR, Kasik JE. Am Rev Respir Dis; 1981 Mar; 123(3):340-2. PubMed ID: 7224346 [Abstract] [Full Text] [Related]
5. Theophylline and salbutamol improve pulmonary function in patients with irreversible chronic obstructive pulmonary disease. Thomas P, Pugsley JA, Stewart JH. Chest; 1992 Jan; 101(1):160-5. PubMed ID: 1729064 [Abstract] [Full Text] [Related]
6. A comparison between inhaled salmeterol and theophylline in the short-term treatment of stable chronic obstructive pulmonary disease. Broseghini C, Testi R, Polese G, Tosatto R, Rossi A. Pulm Pharmacol Ther; 2005 Jan; 18(2):103-8. PubMed ID: 15649852 [Abstract] [Full Text] [Related]
7. The efficacy of orally administered theophylline, inhaled salbutamol, and a combination of the two as chronic therapy in the management of chronic bronchitis with reversible air-flow obstruction. Taylor DR, Buick B, Kinney C, Lowry RC, McDevitt DG. Am Rev Respir Dis; 1985 May; 131(5):747-51. PubMed ID: 4003919 [Abstract] [Full Text] [Related]
8. [Comparing the bronchodilating effects of ipratropium bromide and theophylline]. Dai L, Li X, Yang Y. Zhonghua Jie He He Hu Xi Za Zhi; 1998 Oct; 21(10):609-11. PubMed ID: 11477880 [Abstract] [Full Text] [Related]
9. A randomized, controlled trial of theophylline in patients with severe chronic obstructive pulmonary disease. Murciano D, Auclair MH, Pariente R, Aubier M. N Engl J Med; 1989 Jun 08; 320(23):1521-5. PubMed ID: 2498658 [Abstract] [Full Text] [Related]
16. Dose response relation to oral theophylline in severe chronic obstructive airways disease. Chrystyn H, Mulley BA, Peake MD. BMJ; 1988 Dec 10; 297(6662):1506-10. PubMed ID: 3147048 [Abstract] [Full Text] [Related]
17. The effect of maintenance theophylline therapy on lung work in severe chronic obstructive pulmonary disease while standing and walking. Jenne JW, Siever JR, Druz WS, Solano JV, Cohen SM, Sharp JT. Am Rev Respir Dis; 1984 Oct 10; 130(4):600-5. PubMed ID: 6486559 [Abstract] [Full Text] [Related]
18. Effect of inhaled atropine or metaproterenol in patients with chronic airway obstruction and therapeutic serum theophylline levels. Passamonte PM, Martinez AJ. Chest; 1984 May 10; 85(5):610-5. PubMed ID: 6370619 [Abstract] [Full Text] [Related]
19. Bronchodilator response in chronic obstructive pulmonary disease. Anthonisen NR, Wright EC. Am Rev Respir Dis; 1986 May 10; 133(5):814-9. PubMed ID: 3706890 [Abstract] [Full Text] [Related]
20. Effect of theophylline in chronic obstructive lung disease. Umut S, Gemicioğlu B, Yildirim N, Barlas A, Ozüner Z. Int J Clin Pharmacol Ther Toxicol; 1992 May 10; 30(5):149-52. PubMed ID: 1592541 [Abstract] [Full Text] [Related] Page: [Next] [New Search]